TWD 46.35
(0.65%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | -131.12 Million | 155.64 Million | 217.73 Million | 348.34 Million | - |
Net Income | -420.7 Million | -46.3 Million | -133.69 Million | 7.73 Million | - |
Depreciation & Amortization | 141.6 Million | 183.73 Million | 281.73 Million | 331.25 Million | - |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | 3.86 Million | - | 13.58 Million | 6.79 Million | - |
Change in working capital | 53.61 Million | 23.72 Million | 64.95 Million | 3 Million | - |
Other non-cash items | 10.74 Million | 12.45 Million | 14.82 Million | 17.51 Million | - |
Investing Cash Flow | -6.28 Million | -53.91 Million | -51.82 Million | -92.27 Million | - |
Investments in PPE | -38.31 Million | -16.94 Million | -49.07 Million | -90.51 Million | - |
Acquisitions | 100 Thousand | - | - | - | - |
Investment purchases | - | -37.76 Million | -4.28 Million | -16.56 Million | - |
Sales/Maturities of investments | 33.85 Million | 810 Thousand | - | 13.67 Million | - |
Other Investing Activities | -1.92 Million | -90 Thousand | -594 Thousand | 1.12 Million | - |
Financing Cash Flow | 101.54 Million | -34.78 Million | -170.32 Million | -283.53 Million | - |
Debt repayment | -244.7 Million | -39.39 Million | -172.23 Million | -271.99 Million | - |
Dividends payments | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | 358.45 Million | - | - | - | 10.36 Million |
Other Financing Activities | -12.2 Million | - | 13.51 Million | - | 10.36 Million |
Accounts receivables | 12.38 Million | - | - | - | - |
Accounts payables | 9.38 Million | - | - | - | - |
Inventory | 66.17 Million | 7.02 Million | 66.55 Million | -75.39 Million | - |
Other working capital | -24.94 Million | - | - | - | - |
Cash at beginning of period | 252.87 Million | 185.29 Million | 189.74 Million | 217.41 Million | - |
Cash at end of period | 217.2 Million | 252.87 Million | 185.29 Million | 189.74 Million | - |
Capital Expenditure | -38.31 Million | -16.94 Million | -49.07 Million | -90.51 Million | - |
Effect of forex changes on cash | 194 Thousand | 638 Thousand | -33 Thousand | -204 Thousand | - |
Net cash flow / Change in cash | -35.66 Million | 67.57 Million | -4.45 Million | -27.67 Million | - |
Free Cash Flow | -169.43 Million | 138.69 Million | 168.65 Million | 257.83 Million | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -55.83 Million | -89.9 Million | -420.7 Million | -182.52 Million | -96.94 Million | -63.91 Million |
Depreciation & Amortization | 22.35 Million | 22.21 Million | 141.6 Million | 32.11 Million | 35.37 Million | 36.4 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | 3.86 Million | - | - | - |
Change in working capital | 33.11 Million | 58.77 Million | 53.61 Million | 48.12 Million | -30.65 Million | 6.73 Million |
Other non-cash items | -482 Thousand | 1.82 Million | 10.74 Million | 987 Thousand | 3.47 Million | 2.94 Million |
Investing Cash Flow | -43.29 Million | 4.65 Million | -6.28 Million | -47.83 Million | 19.75 Million | -1.19 Million |
Investments in PPE | -13.57 Million | -27.49 Million | -38.31 Million | -16.05 Million | -11.87 Million | -3.16 Million |
Acquisitions | 26 Thousand | - | - | - | - | - |
Investment purchases | - | - | - | - | -34.03 Million | - |
Sales/Maturities of investments | -28.76 Million | 31.82 Million | 33.85 Million | -31.88 Million | 31.7 Million | 1.79 Million |
Other Investing Activities | -977 Thousand | -47 Thousand | -1.92 Million | 103 Thousand | -66 Thousand | 71 Thousand |
Financing Cash Flow | -30.5 Million | 409.62 Million | 101.54 Million | 95.64 Million | 38.65 Million | -41.86 Million |
Debt repayment | -28.93 Million | -44.81 Million | -244.7 Million | -98.7 Million | -316.75 Million | -38.81 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 456 Million | 358.45 Million | - | 358.45 Million | - |
Other Financing Activities | 77.42 Million | - | - | - | - | - |
Accounts receivables | 19.84 Million | - | - | - | - | - |
Accounts payables | 2.68 Million | - | - | - | - | - |
Inventory | 20.6 Million | 57.23 Million | 66.17 Million | 50.96 Million | -2.43 Million | 8.85 Million |
Other working capital | -10.01 Million | - | - | - | - | - |
Cash at beginning of period | 621.51 Million | 217.2 Million | 252.87 Million | 186.41 Million | 214.18 Million | 274.95 Million |
Cash at end of period | 547.93 Million | 621.51 Million | 217.2 Million | 217.2 Million | 186.41 Million | 214.18 Million |
Capital Expenditure | -13.57 Million | -27.49 Million | -38.31 Million | -16.05 Million | -11.87 Million | -3.16 Million |
Effect of forex changes on cash | 2.21 Million | 126 Thousand | 194 Thousand | -11 Thousand | 95 Thousand | 171 Thousand |
Net cash flow / Change in cash | -73.57 Million | 404.31 Million | -35.66 Million | 30.78 Million | -27.77 Million | -60.76 Million |
Free Cash Flow | -15.57 Million | -37.57 Million | -169.43 Million | -33.06 Million | -98.15 Million | -21.04 Million |
INSECTICID
MEHIF
LSI
0695
6406
IGPL